Description: Synapse of EAAT2 Glutamate Transport - Patient education illustration depicting the synapse model with neurotransmitters used as a physiological and pathological comparison to the affects of FDA-approved drugs on ALS. Illustration for an inside feature article for patient education of and biochemical pathway that has been studied and considered to be a leading cause of Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease). This is a model of the neural signaling mechanism and the glial cells that support it by removing glutamate. In ALS, this protein is missing and therefore is unable to remove glutamate.


© 2002 Fairman Studios, LLC. All Rights Reserved.
To request permission & acquire license for usage, e-mail Fairman Studios.

close this window